Markus Axelsson

5.0k citations
80 papers · 2.7k indexed · 1 hit paper · h-index 26

Impact in

    • Multiple Sclerosis Research Studies
  • Neurology top 1%
    • Peripheral Neuropathies and Disorders
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Amyotrophic Lateral Sclerosis Research

Papers in

    • Multiple Sclerosis Research Studies 48
    • Systemic Sclerosis and Related Diseases 6
    • Peripheral Neuropathies and Disorders 25
    • Neuroinflammation and Neurodegeneration Mechanisms 6
    • Autoimmune Neurological Disorders and Treatments 5

Markus Axelsson

71 papers receiving 2.6k citations

Hit Papers

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein 2017 · 325 citations
3252017202620202023100200300

Peers

Markus Axelsson
Comparison fields: 5 of 98
  • Pathology and Forensic Medicine 1.7k
  • Neurology 892
  • Neurology 358
  • Developmental Neuroscience 174
  • Rheumatology 376
Replace Clas Malmeström with:
Clas Malmeström Sweden
Davorka Tomic Switzerland
Paola Cavalla Italy
Lenka Novakova Sweden
Markus Bergmann Germany
Lixin Zhang-Auberson Switzerland
Barbara Kornek Austria
Juan J. Archelos Austria
Imke Metz Germany
Bonaventura Casanova Spain
Markus Axelsson relative to Clas Malmeström Sweden Clas Malmeström's profile →
Citations per field
00.5×1.5×
Clas Malmeström · 1×
Citations per year

Countries citing papers authored by Markus Axelsson

Since Specialization
Citations

This map shows the geographic impact of Markus Axelsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Axelsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Axelsson more than expected).

Fields of papers citing papers by Markus Axelsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Axelsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Axelsson. The network helps show where Markus Axelsson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Markus Axelsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Axelsson Line = papers co-authored together Markus Axelsson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20260
2 20250
3 20250
4 20251
5 20241
6 20247
7 20243
8 202320
9 20230
10 202320
11 20232
12 202220
13 202213
14 202210
15 20228
16 201926
17 201926
18 201841
19
Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology
20152
20 2013102

About Markus Axelsson

Markus Axelsson is a scholar working on Pathology and Forensic Medicine, Neurology, Developmental Neuroscience, Rheumatology and Neurology, having authored 80 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (48 papers), Peripheral Neuropathies and Disorders (25 papers), Polyomavirus and related diseases (9 papers), Systemic Lupus Erythematosus Research (9 papers), Neurogenesis and neuroplasticity mechanisms (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Systemic Sclerosis and Related Diseases (6 papers) and Autoimmune Neurological Disorders and Treatments (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Neurology (892 citations), Neurology (358 citations), Developmental Neuroscience (174 citations) and Rheumatology (376 citations). Markus Axelsson has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Jan Lycke, Clas Malmeström, Henrik Zetterberg, Lenka Novakova, Kaj Blennow, Fredrik Piehl, Anders Svenningsson, Peter Sundström, Tomas Olsson and Martin Gunnarsson. Their work appears in journals such as Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Acta Neurologica Scandinavica, European Journal of Neurology and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026